Gene Therapy Research Institution Company Overview
- Founded
- 2014
- Status
- Private
- Latest Deal Type
- 2ndary - Private
- Financing Rounds
- 1
- Investments
- 1
Gene Therapy Research Institution Company General Information
Description
Developer of gene therapy treatments. The company is engaged in research and development of treatments and drugs from gene therapy for diseases using molecular imaging techniques such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Drug Discovery
Primary Office
- Kanagawa Science Park Innovation Center Building West 714A
- 2-1, Sakado 3-chome, Takatsu-ku, Kawasaki
- Kanagawa, 213
- Japan
+81 000-000-0000
Gene Therapy Research Institution Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Gene Therapy Research Institution Company‘s full profile, request access.
Request a free trialGene Therapy Research Institution Company Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Katsuhito Asai | President | ||
| Shinichi Muramatsu | Director | ||
| Toshihiko Sato | Director |
Gene Therapy Research Institution Company Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000-0000000000 0 | 02-Aug-2017 | 00000 0000000 | Biotechnology | 000000000 0000 |